← Open Payments lookup

MARY OSAGIE: Open Payments

NPI 1508564097 · ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$636 in 36 payments from 9 companies in 2025. Trend: 2023 $189 · 2024 $322 · 2025 $636

Food & beverage: $636
CompanyPaymentsAmount
Alkermes, Inc.11$205
Teva Pharmaceuticals USA, Inc.7$130
ABBVIE INC.5$75
Otsuka America Pharmaceutical, Inc.4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54
Lundbeck LLC2$35
E.R. Squibb & Sons, L.L.C.2$35
Axsome Therapeutics, Inc.1$18
Janssen Pharmaceuticals, Inc1$15

Products named: ARISTADA, REXULTI, AUSTEDO XR, VRAYLAR, CAPLYTA, UZEDY, COBENFY, Auvelity.

Industry payments across NJ — which companies pay providers there.